Part 2: Using Depth of Response and MRD as Goals for Multiple Myeloma - Targeted Oncology

Retrieved on: 2022-05-02 20:03:17

Tags for this article:

Click the tags to see associated articles and topics

Part 2: Using Depth of Response and MRD as Goals for Multiple Myeloma - Targeted Oncology. View article details on hiswai:

Excerpt

Using Anti-CD38 Monoclonal Antibodies as Treatment in Multiple Myeloma ... In a patient who's had a PR, a 65% reduction [in serum monoclonal ...

Article found on: www.targetedonc.com